Evaluation shows zinc–copper alloys promote bone formation and improve corrosion resistance, suggesting clinical benefits for bone defect treatment.
The repair of large segmental bone defects remains a major clinical challenge. Traditional bone repair materials often suffer from mismatched degradation rates, insufficient mechanical strength, or limited bioactivity. Biodegradable zinc alloys have emerged as potential alternatives due to their suitable degradation rate and good biocompatibility, though their bioactivity requires further enhancement. In this study, a zinc phosphate (ZnP) coating was applied on the surface of zinc–copper (Zn–Cu) alloy via a phosphate chemical conversion method, and the corrosion resistance, wear resistance, and osteogenic properties of the coating were systematically evaluated. Results showed that the ZnP coating prepared at pH = 2.5 exhibited a dense structure and high crystallinity, reducing the corrosion rate to 0.010 μm/year and increasing the ultimate tensile strength to 117.03 ± 0.78 MPa, significantly improving the wear and corrosion resistance of the alloy. In vivo experiments demonstrated that the material markedly promoted new bone formation and osseointegration. Micro-computed tomography (Micro-CT) revealed that key indicators such as bone volume fraction (approximately 50.26%) and trabecular number (approximately 161.31/mm3) were superior to those of the β-tricalcium phosphate (β-TCP) group and the control group. Histological analysis confirmed its excellent osteogenic activity and mineralization capacity. Biosafety assessments indicated no systemic toxic reactions. The ZnP-coated Zn-1Cu alloy showed promising application in treatment of bone defect.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: